| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/19/2000 | EP0971687A1 Aqueous solutions of salicylic acid derivatives |
| 01/19/2000 | EP0971684A1 Keratotic plug remover |
| 01/19/2000 | EP0971669A2 Vaginal tampon and process for producing the same |
| 01/19/2000 | EP0971662A1 Fatty acid esters of glycolic acid and its salts as permeation enhancers |
| 01/19/2000 | EP0971641A1 Intravesical drug delivery system |
| 01/19/2000 | EP0859751B1 Semi-fluorinated alkanes and their use |
| 01/19/2000 | EP0719209B1 Multilayer halogen-free barrier film |
| 01/19/2000 | EP0696917B1 Method for inhibiting posterior capsule opacification |
| 01/19/2000 | EP0593746B1 Transdermal drug delivery system |
| 01/19/2000 | CN2358883Y Floating-point coated medicine plaster |
| 01/19/2000 | CN2358882Y 'yuntonglin'-external used medicine paste |
| 01/19/2000 | CN2358881Y Silver amalgam capsule for dentisty |
| 01/19/2000 | CN1242045A Immunotherapy and improved vaccines |
| 01/19/2000 | CN1241979A Valve for aerosol container |
| 01/19/2000 | CN1241946A Immediately disintegrable medicinal compositions |
| 01/19/2000 | CN1241940A Mucosal administration of substances to mammals |
| 01/19/2000 | CN1241906A Adjuvant for transcutaneous immunization |
| 01/19/2000 | CN1241662A Long-acting wide-spectrum antiseptic nanometer silver fabric and its making method |
| 01/19/2000 | CN1241440A Preparation of onychomycosis liquor |
| 01/19/2000 | CN1241434A Herb medicine's composition by novel prescription and preparation for preaparing the same |
| 01/19/2000 | CN1241433A Lushiyuyan capsule for treating hepatosis and its preparation |
| 01/19/2000 | CN1241426A Convalescence capsule for treating gonarrhea and its preparation process |
| 01/19/2000 | CN1241410A Plaster for treating appendicitis and intestinal adhesion |
| 01/19/2000 | CN1241405A Oral linmerjing as one kind of powerful anti-bacterial medicine |
| 01/19/2000 | CN1241404A Avermectin-or ivermectin-containing slow releasing injecta |
| 01/19/2000 | CN1048495C Tetrahydropyran derivatives, its producing process and their medical composition containing them |
| 01/19/2000 | CN1048406C Compound flavescent sophora root injection for animals |
| 01/19/2000 | CN1048398C Controlled release pharmaceutical preparation and method for producing the same |
| 01/19/2000 | CN1048397C Hydrogel Slow-releasing agent |
| 01/19/2000 | CN1048396C Granular preparation |
| 01/19/2000 | CN1048395C Pharmaceutical granulate |
| 01/19/2000 | CN1048394C Chlordimethasone aerosol |
| 01/19/2000 | CN1048393C Aqueous drug composition having property of reversible thermosetting gelation |
| 01/18/2000 | US6015844 Matrix of insoluble collagen reinforced by layer of synthetic bioabsorbable material having oil droplets dispersed; grafts, prosthetics |
| 01/18/2000 | US6015835 Methods of inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general |
| 01/18/2000 | US6015832 Methods of inactivating bacteria including bacterial spores |
| 01/18/2000 | US6015810 Aqueous ophthalmic solution containing apafant as active ingredient |
| 01/18/2000 | US6015712 Antisense modulation of FADD expression |
| 01/18/2000 | US6015688 Transferrin receptor genes |
| 01/18/2000 | US6015599 High vertical aspect ratio thin film structures |
| 01/18/2000 | US6015577 Treatment of strokes |
| 01/18/2000 | US6015576 Method for inducing a systemic immune response to an antigen |
| 01/18/2000 | US6015573 Treatment of resistant herpes virus with nucleoside phosphate esters |
| 01/18/2000 | US6015572 Glial cells with neurotropic factors for nerve damage |
| 01/18/2000 | US6015568 Anhydrous stable retinol based cosmetic or pharmaceutical composition |
| 01/18/2000 | US6015551 Copolymers of carboxylic acids and multiply olefinically unsaturated carboxylic acid derivatives and their use as thickeners and dispergents |
| 01/18/2000 | US6015547 Zinc ion with anions for solutions |
| 01/18/2000 | US6015546 Atomizing a solution or dispersion of protein wall forming material |
| 01/18/2000 | CA2184433C Retinoid formulations in porous microspheres for reduced irritation and enhanced stability |
| 01/18/2000 | CA2147089C Cosmetic and/or dermatological composition containing a glycerol tri(alpha-hydroxyacylate) as the only glycerol precursor |
| 01/18/2000 | CA2013474C Cyclophosphamide - alanine lyophilizates |
| 01/18/2000 | CA2004049C Topical application of medicament in a binder |
| 01/17/2000 | CA2243619A1 Chitosan- and xanthan-based polyionic hydrogels for the stabilization and controlled release of vitamins |
| 01/15/2000 | CA2239931A1 Pharmaceutical tablet comprising norfloxacin |
| 01/14/2000 | WO2000003736A1 Prostaglandin product |
| 01/13/2000 | WO2000001694A1 Paroxetine methanesulfonate |
| 01/13/2000 | WO2000001693A1 Paroxetine maleate polymorph and pharmaceutical compositions containing it |
| 01/13/2000 | WO2000001474A1 Method for producing aqueous emulsions or suspensions |
| 01/13/2000 | WO2000001437A1 Apparatus for and methods of administering volatile substances into an inhalation flow path |
| 01/13/2000 | WO2000001428A1 Diphasic injection composition, in particular useful in reparative and plastic surgery |
| 01/13/2000 | WO2000001416A1 Pharmaceutical compositions containing low-melting waxes |
| 01/13/2000 | WO2000001395A1 Hypo-osmotic saline solutions, method for preparing same and medicines based on said solutions |
| 01/13/2000 | WO2000001394A1 Biocompatible and biodegradable compositions containing hyaluronic acid and the derivatives thereof for the treatment of ulcers in the digestive apparatus |
| 01/13/2000 | WO2000001393A2 OLIGONUCLEOTIDE INHIBITORS OF bcl-xL |
| 01/13/2000 | WO2000001390A1 Topical aciclovir formulations |
| 01/13/2000 | WO2000001384A1 Ketotifen preparation for percutaneous absorption |
| 01/13/2000 | WO2000001378A1 Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection |
| 01/13/2000 | WO2000001374A1 Therapeutic system with addition of nacreous pigments |
| 01/13/2000 | WO2000001373A1 Materials and methods relating to encapsulation |
| 01/13/2000 | WO2000001372A2 Chewable oral unit dosage |
| 01/13/2000 | WO2000001371A1 Thixotropic formulations for filling capsules |
| 01/13/2000 | WO2000001370A1 Edible product consisting of a core and at least one coating containing a natural resin |
| 01/13/2000 | WO2000001369A1 Sustained release pharmaceutical preparation |
| 01/13/2000 | WO2000001368A1 Anti-inflammatory pharmaceutical formulations |
| 01/13/2000 | WO2000001366A1 A method of administering liposomal encapsulated taxane |
| 01/13/2000 | WO2000001365A1 Prolonged release ophthalmic compositions containing a fluoroquinolone |
| 01/13/2000 | WO2000001364A1 Stable pharmaceutical compositions of thieno [3,2-c] pyridine derivatives |
| 01/13/2000 | WO2000001363A2 Enteric coated pharmaceutical formulation |
| 01/13/2000 | WO2000001360A1 Perfume compositions |
| 01/13/2000 | WO2000001351A1 Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |
| 01/13/2000 | WO2000001321A1 Methods and compositions for producing a cooling effect in tissues |
| 01/13/2000 | WO1999056770A3 Novel therapy for treatment of lysosomal storage disease |
| 01/13/2000 | WO1999055353A3 Protein formulations |
| 01/13/2000 | WO1999055312A3 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 01/13/2000 | WO1999049716A3 Method for producing liposomal formulations of active agents by high-pressure homogenisation |
| 01/13/2000 | WO1999047252A3 Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
| 01/13/2000 | WO1999036104A3 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these |
| 01/13/2000 | DE19831263A1 Darreichungsform Dosage form |
| 01/13/2000 | DE19830732A1 Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff A composition comprising at least one lipid levels influencing drug |
| 01/13/2000 | DE19830651A1 Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung Steroid-containing patch, process for its preparation and use |
| 01/13/2000 | DE19830649A1 Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe The topical patch with NSAIDs with acid group |
| 01/13/2000 | DE19830648A1 Glyceroltrinitrathaltige Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung Glyceroltrinitrathaltige composition, process for their preparation and their use |
| 01/13/2000 | DE19830246A1 Pharmazeutische Zubereitung Pharmaceutical composition |
| 01/13/2000 | DE19829647A1 Verfahren zur Herstellung von wäßrigen Emulsionen oder Suspensionen A process for the preparation of aqueous emulsions or suspensions |
| 01/13/2000 | CA2337273A1 Thixotropic formulations for filling capsules |
| 01/13/2000 | CA2336384A1 Oligonucleotide inhibitors of bcl-xl |
| 01/13/2000 | CA2335920A1 Hypo-osmotic saline solutions, method for preparing same and medicines based on said solutions |
| 01/13/2000 | CA2335824A1 Therapeutic system with addition of nacreous pigments |
| 01/13/2000 | CA2303094A1 Methods and compositions for producing a cooling effect in tissues |
| 01/12/2000 | EP0970998A1 Wax ester of vaseline-like consistency |